medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2014, Number 1

<< Back Next >>

Perinatol Reprod Hum 2014; 28 (1)

Main ophthalmologic manifestations in diabetic pregnant women

Martínez-Romero L, Salgado-Valladares MB

Language: Spanish
References: 18
Page: 16-21
PDF size: 225.74 Kb.


ABSTRACT

The evidence of the epidemiologic transition in the world is associated with the progression of chronic degenerative diseases, including diabetes mellitus. The impact this condition can have in the patient’s course of life is deleterious and the population at risk in reproductive ages, ranging from the second to the third decades of life, can have significant effects on the mother-child binome, making imperative for a adequate obstetric outcome the diagnosis of pregestational and gestational diabetes mellitus and its timely treatment, thus avoiding secondary complications in the mother and fetus and avoiding the increase in the cost-benefit of these patients. Regarding ocular health, anatomical alterations of the retina and lens are secondary complications in the life of diabetic patients, which can progress during pregnancy and leave important sequelae, with decreased function.


REFERENCES

  1. American Diabetes Association. Standards of medical care in diabetes 2008. Diabetes Care. 2008; 31: S12-S54.

  2. American Diabetes Association. Standards of medical care in Diabetes 2010. Diabetes Care. 2010; 33: S11-S61.

  3. Organización Mundial de la Salud. Centro de prensa: nota descriptiva Núm. 312, septiembre de 2012.

  4. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH et al. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy study. Am J Obstet Gynecol. 1991; 164: 103-11.

  5. Calle MS, López-Guajardo L, García J, Fonseca A, Pallardo F, Martín P. Evolución de la retinopatía diabética durante el embarazo. Arch Soc Esp Oftalmol. 1997; 9: 653-8.

  6. Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990; 13: 34-40.

  7. Scucces M. Diabetes y embarazo. Rev Obstet Ginecol Venez. 2011; 71: 3-12.

  8. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care. 2000;23:390-404.

  9. Gattullo B, Olubummo C. Evaluación de la diabetes gestacional. Rev Nursing. 2010; 28: 40-2.

  10. Ricart W. Gestational diabetes and maternal obesity: lessons from the studies performed by the Spanish Diabetes and Pregnancy Group. Endocrinol Nutr. 2006; 52: 287-9.

  11. Márquez A, Lang J, Valdés LA, Cruz J, Guerrero E. Prediabetes y diabetes gestacional. Rev Cubana Endocrinol. 2011; 22: 462-71.

  12. Quiróz-Mercado H. Retina. Diagnóstico y tratamiento. Madrid: McGraw-Hill Interamericana; 1996.

  13. Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol. 2005; 16: 308-14.

  14. ETDRS (Early Treatment Diabetic Retinopathy Study Research Group). Fundus photographic, risk factors for progression of diabetic retinopathy. Ophthalmology. 1991; 98: 823-33.

  15. Lovestam M, Agardh C, Aberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type I diabetic patient. Diabetes Med. 1997; 14: 1059-65.

  16. Rosenn B, Miodovnik M, Kranias G, Khoury J, Combs C, Mimouni F. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol. 1992; 166: 1214-8.

  17. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A et al. for the Society of Obstetricians and Gynecologist of Canada. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can. 2007; 29: 927-44.

  18. Nazzer J, García M, Cifuentes L. Malformaciones congénitas en hijos de madres con diabetes gestacional. Rev Méd Chile. 2005; 133: 547-54.




2020     |     www.medigraphic.com